Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Oncolytic and local immunotherapy

Original research

Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy

Online download statistics by month:

Online download statistics by month: July 2022 to March 2024

	Abstract	Full	Pdf
Jul 2022	427	455	166
Aug 2022	235	276	100
Sep 2022	158	169	259
Oct 2022	156	158	70
Nov 2022	118	119	48
Dec 2022	92	93	23
Jan 2023	85	85	21
Feb 2023	108	111	46
Mar 2023	98	98	34
Apr 2023	58	58	24
May 2023	28	29	10
Jun 2023	52	53	26
Jul 2023	40	40	27
Aug 2023	37	37	21
Sep 2023	23	25	9
Oct 2023	37	39	14
Nov 2023	35	35	14
Dec 2023	36	36	18
Jan 2024	49	51	27
Feb 2024	38	38	15
Mar 2024	39	39	83
Total	1949	2044	1055